Denmark: Violation of good manufacturing practice is source of contaminated antibiotic
The Danish Medicines Agency seeks to bring the matter to European inspectors to increase awareness of potential problems in the future.
by ulrich quistgaard, translated by daniel pedersen
There have been some clear and pretty basic violations of EU rules for good manufacturing practices (GMP) at the contract manufacturing organization that made the antibiotic Dicillin that infected Danish and Icelandic patients with multiresistant bacteria, says the Danish Medicines Agency.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
